Skip to main content
. 2020 Mar;8(5):230. doi: 10.21037/atm.2020.01.32

Figure 5.

Figure 5

Nomogram to predict the survival of patients with hepatocellular carcinoma undergoing immunotherapy. HCV, hepatitis C virus; PFS, progression-free survival.